Pediatric Blood & Cancer · 2022 · 16 citations · 22 references
MedicineHematologyPediatricsPediatric EpidemiologyPediatric HematologyTransfusion MedicineAnemiaIron Overload ManagementMedicaidPediatric TransfusionSickle Cell DiseaseTransfusional Iron OverloadHydroxyurea TherapyIron Overload MonitoringPediatric Iron ChelationPediatric Iron Overload ManagementPediatric Transfusional Iron OverloadSickle Cell AnemiaSickle Cell Disease Transfusion TherapyTransfusion Indications
BACKGROUND: There have been significant changes in clinical guidelines for sickle cell disease (SCD) over the past two decades, including updated indications for hydroxyurea, transfusions, and iron overload management. In practice however, there are few studies that examine SCD care utilization over time. METHODS: We conducted a serial cross-sectional cohort study of pediatric SCD patients from 2004 to 2019 using Georgia Medicaid claims data. For each year, we reported receipt of any transfusion, chronic transfusion, or three or more filled hydroxyurea prescriptions. For children receiving chronic transfusion (six or more annual transfusions), we evaluated iron overload diagnosis, monitoring, and chelation use. Among children with sickle cell anemia (SCA), we examined rates of transfusions and hydroxyurea use. The Cochran-Armitage test was used to assess trend. RESULTS: There were 5316 unique children 2-18 years old with SCD enrolled in Georgia Medicaid from 2004 to 2019. Children receiving any transfusion increased from 2004 to 2010, then stabilized. In SCA patients, chronic transfusions initially increased from 2004 to 2010, then stabilized from 2010 to 2019. For chronically transfused children, monitoring of iron burden and filled chelator prescriptions both increased significantly. Hydroxyurea use in SCA patients increased from 12% to 37%, with increases noted within each age group, most notably from 21% to 60% in the 13-18-year-old cohort. CONCLUSION: We demonstrated changes in SCD care utilization over time, including increased hydroxyurea use, changes in transfusion rates, and increased attention to iron overload management. While trends in clinical management do follow updates in treatment guidelines, there is still delayed and suboptimal uptake of guideline recommendations in pediatric SCD patients.
22
Robert J. Adams, Lewis L. Hsu, Elliott Vichinsky et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text
Medicine, Hematology, Pediatrics +10
Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 514 citations · Full text
Medicine, Hematology, Pediatrics +12